Micro-dosing Intravenous Buprenorphine to Rapidly Transition From Full Opioid Agonists
Ashish P Thakrar1, Lindsay Jablonski, Jessica Ratner
1Department of Medicine, Division of Addiction Medicine, Johns Hopkins University School of Medicine, Baltimore, MD (APT); Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, MD (LJ); Department of Medicine, Division of Addiction Medicine, Johns Hopkins University School of Medicine, Baltimore, MD (JR); Johns Hopkins University School of Medicine, Department of Medicine, Division of Addiction Medicine, Johns Hopkins University School of Medicine, Baltimore, MD (DAR).
Abstract:
For patients with opioid use disorder transitioning from methadone or requiring opioid analgesia, initiating buprenorphine for opioid use disorder can be difficult because of the risk of precipitated withdrawal. Low-dose initiation, also known as micro-dosing, is an alternative to standard initiation. Prior studies relied on nonstandard dosing of tablets or films, patches, or buccal formulations, all of which are unavailable in many hospitals. We report a novel approach to micro-dosing using intravenous buprenorphine. Two patients, one on methadone maintenance and another requiring postoperative opioid analgesia, were transitioned to buprenorphine with concurrent full-agonist opioids and without precipitated withdrawal.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Analgesia and Pain Management
Desensitization and Tachyphylaxis
Drug Accumulation During Multiple Dosing: Repetitive IV Injections


